HONG KONG, March 31, 2011 /PRNewswire-Asia/ -- Golden Meditech Holdings Limited ("Golden Meditech" or the "Company," - 801.HK; 910801.TW) wishes to announce that the Group's Chairman, Mr. KAM Yuen and his family has purchased 11.532 million shares of the Company on March 29 & 30, 2011, at the average price of HK$1.3152 per share via a representative holding company, as per disclosed to the Hong Kong Exchanges and Clearings Limited. As a result of which, Mr. Kam and family have increased their interest in the Company from 19.88% to 20.49%.
Mr. Kam is the founder of the Company with over 20 years of experience in healthcare industry in China. Under his helm, the Group has grown from a single product medical devices producer to being a leading healthcare enterprise in China and a leader in multiple markets, including medical devices, healthcare management and cord blood banking.
About Golden Meditech Holdings Limited
Golden Meditech Holdings Limited is China's leading integrated-healthcare device and service operator, and the first medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEx). Golden Meditech is a first-mover in China, having established dominant positions in medical devices and healthcare services markets over the years, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.
For enquiries, please contact:
Investor Relations Department
Golden Meditech Holdings Limited
Address: 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong
Tel: +852-3605-8180
Fax: +852-3605-8181
Email: ir@goldenmeditech.com
